Newer LVAD has high readmission rates, study says

09/16/2010 | Doctor's Guide

Newer continuous-flow left ventricular assist devices were linked to unacceptably high hospital readmission rates, which could limit their use in advanced heart failure care, researchers said. Study data showed cumulative incidences of hospital readmission were 34.6% at three months, 60.6% at six months and 84.6% at one year.

View Full Article in:

Doctor's Guide

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA